Pharmaceutical Drug Delivery Market Research Reports & Industry Analysis
Drug delivery refers to the method or process of administering a pharmaceutical compound to a patient's body, ensuring it reaches the intended target site in the right dosage and with the desired release profile. Understanding this complex market sector can be a challenge, and that's where MarketResearch.com can help. Our comprehensive pharmaceutical drug delivery industry reports provide invaluable insights for stakeholders across the healthcare spectrum.
New Pharmaceutical Drug Delivery Market Insights
- From transdermal patches and implantable devices, to autoinjectors and microneedle technologies, our reports cover it all.
- In addition to drug delivery market sizing and growth projections, our reports explain crucial drivers, challenges, technological innovations, and emerging trends that shape the industry.
- Packed with forward-looking insights and expert commentary, our reports help ensure you are well-prepared for a variety of shifting market scenarios.
Your Guide to Navigating the Future
With over two decades of experience in market research, MarketResearch.com is a trusted leader in the field. Top investment banks, management consulting firms, and Fortune 500 multinational corporations have turned to us for insights on an ongoing basis. Our curated selection of reports brings together the expertise of hundreds of leading firms, providing you with a one-stop resource for the most up-to-date and in-depth pharmaceutical drug delivery market research.
Drug Delivery Industry Research & Market Reports
-
Global Closed System Drug Transfer Devices Market 2024-2032
... A closed system drug transfer device (CSTD) is a specialized medical device engineered to facilitate the safe transfer of hazardous drugs while preventing contamination from external sources and blocking the escape of hazardous substances or ... Read More
-
RNA Interference (RNAi) Drug Delivery Market Report by Application (Infectious Disease, Cardiology, Oncology, Neurology, Ophthalmology, Urology, Metabolic Disorders, and Others), Technology (Nanoparticle Drug Delivery, Pulmonary Drug Delivery, Nucleic Acid Drug Delivery, Aptamer Drug Delivery), and Region 2025-2033
... 17.75% during 2025-2033. Ribonucleic acid interference (RNAi) drug delivery refers to a therapeutic solution to monitor gene expression or mutations. RNAi drug delivery is usually administered through intravenous, intra-dermal and intraperitoneal injections and topical delivery ... Read More
-
Hormone Replacement Therapy Market Report by Product (Estrogen Replacement Therapy, Human Growth Hormone Replacement Therapy, Thyroid Replacement Therapy, Testosterone Replacement Therapy, and Others), Route of Administration (Oral, Parenteral, Transdermal), Type of Disease (Menopause, Hypothyroidism, Male Hypogonadism, Growth Hormone Deficiency, and Others), and Region 2025-2033
... 2025-2033. The rising prevalence of hormonal disorders, increased awareness and acceptance of HRT, expanding geriatric population, significant technological advancements and ongoing innovations in delivery methods, supportive government initiatives and reimbursement policies are some of the ... Read More
-
Nasal Drug Delivery Technology
... 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Nasal Sprays, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$66.9 Billion by the ... Read More
-
Oral Thin Films
... at a CAGR of 12.4% over the analysis period 2024-2030. Sublingual Film, one of the segments analyzed in the report, is expected to record a 11.7% CAGR and reach US$3.9 Billion by the end of ... Read More
-
Implantable Ports
... CAGR of 3.1% over the analysis period 2024-2030. Single-Lumen Implantable Ports, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$186.6 Million by the end of the ... Read More
-
Novel Drug Delivery Systems (NDDS)
... Billion by 2030, growing at a CAGR of 21.9% over the analysis period 2024-2030. Nanoparticles, one of the segments analyzed in the report, is expected to record a 21.4% CAGR and reach US$51.9 Billion by ... Read More
-
Topical Drug Delivery
... at a CAGR of 5.2% over the analysis period 2024-2030. Semi-Solid Formulations, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$76.7 Billion by the end of ... Read More
-
Electronic Drug Delivery Systems
... 2030, growing at a CAGR of 8.1% over the analysis period 2024-2030. Wearable Infusion Pumps, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$8.7 Billion by ... Read More
-
Transdermal Scopolamine
... CAGR of 5.3% over the analysis period 2024-2030. The U.S. Market is Estimated at US$141.9 Million While China is Forecast to Grow at 5.1% CAGR The Transdermal Scopolamine market in the U.S. is estimated at ... Read More
-
Non-opioid Pain Patch
... at a CAGR of 2.2% over the analysis period 2024-2030. Lidocaine Patches, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$1.5 Billion by the end of ... Read More
-
Microfluidics Market by Product (Chip, Sensor, Valve, Pump, Needle), Material (Silicon, Polymer), Application (Diagnostics (Clinical, PoC), Research (Proteomic, Genomics, Cell), Therapeutics (Drug Delivery, Wearables)), End User- Global Forecast to 2029
... to a number of important factors. The growing requirement for point-of-care diagnostics is one of an important factor. The necessity for fast and accurate diagnosis has risen due to the increase in chronic diseases like ... Read More
-
Implantable Drug Delivery Devices
... 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Contraceptive Implants, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$9.8 Billion by the ... Read More
-
Controlled Release Drug Delivery
... 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. Feedback Regulated Release Mechanism, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$26.3 Billion ... Read More
-
Connected Drug Delivery Devices
... 2030, growing at a CAGR of 21.5% over the analysis period 2024-2030. Standalone Components & Software, one of the segments analyzed in the report, is expected to record a 20.2% CAGR and reach US$14.8 Billion ... Read More
-
Pulmonary / Respiratory Drug Delivery
... Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Metered Dose Inhalers, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$35.9 ... Read More
-
Autoinjectors
... 15.9% over the analysis period 2024-2030. Rheumatoid Arthritis Therapy, one of the segments analyzed in the report, is expected to record a 15.8% CAGR and reach US$47.6 Billion by the end of the analysis period. ... Read More
-
Smart Pills
... CAGR of 11.6% over the analysis period 2024-2030. Esophagus Target Area, one of the segments analyzed in the report, is expected to record a 12.1% CAGR and reach US$238.4 Million by the end of the ... Read More
-
Transdermal Drug Delivery
... at a CAGR of 16.6% over the analysis period 2024-2030. Passive Delivery System, one of the segments analyzed in the report, is expected to record a 15.1% CAGR and reach US$123.5 Billion by the end ... Read More
-
Global Auto-Injectors Market - 2025-2033
... 2025-2033. Auto-injectors are specialized medical devices used to self-administer premeasured dosages of medication, typically in emergency situations or for chronic diseases. These devices often have a spring-loaded syringe that allows users to inject medication without ... Read More
-
U.S. Smart Pills Market - 2024-2031
... the forecast period 2024-2031. Smart pills are advanced medical devices that integrate technology with pharmaceuticals to enhance healthcare delivery. They typically consist of ingestible sensors activated upon ingestion, these sensors collect various health-related data as ... Read More
-
Global Disposable Autoinjectors Market - 2025-2033
... forecast period 2025-2033. A disposable autoinjector is a medical device designed for the subcutaneous or intramuscular self-administration of medication, which is typically in the form of a pre-filled syringe. These devices are characterized by their ... Read More
-
Global Drug Delivery Devices Market - 2025-2033
... during the forecast period 2025-2033. Drug delivery devices are crucial in modern medicine, transporting pharmaceutical compounds to specific body sites for desired therapeutic effects. They use various methods, formulations, and technologies to optimize drug administration, ... Read More
-
2025 Global: Biopharmaceutical Drug Delivery Technologies Market - Innovative Markets Forecast (2031) report
... accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the only ... Read More
-
2025 Global: Biopharmaceutical Drug Delivery Devices Market - Innovative Markets Forecast (2031) report
... accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the only ... Read More
Research Assistance
